image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Plus500 - Significant director buying

April 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 726p
I’ve been writing this newsletter for almost 20 years and it’s unprecedented for virtually every sector to experience such steep sell-offs (aside from parts of the credit crunch era). But this heightened volatility is a great friend for Plus500, which provides an online platform for retail customers to trade in financial derivatives such as CFDs (contracts for difference) and which has just announced that its first quarter in 2020 is trading substantially ahead of the last quarter of 2019. As broker Liberum puts it, “Newsflow drives customers…volatility drives revenues and this period is seeing both.”Founded in 2008, Plus 500 provides commission free trading in CFDs, products that allow investors to e ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X